Sarah B Thomson

5PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyMicro- and nanosystemsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 22, 2026
Silencing of human <i>HTT</i> by targeted CRISPR/dCas9-mediated epigenetic editing.

Yi Lin Tay, Sarah B Thomson, Silvia Hnatova

|Dec 12, 2022
AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington's disease mouse model.

Sarah B Thomson, Anouk Stam, Cynthia Brouwers

|May 20, 2022
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components.

Pardis Kazemian, Si-Yue Yu, Sarah B Thomson

|Jul 01, 2021
Author Correction: The current landscape of nucleic acid therapeutics.

Jayesh A Kulkarni, Dominik Witzigmann, Sarah B Thomson

|Jun 01, 2021
The current landscape of nucleic acid therapeutics.

Jayesh A Kulkarni, Dominik Witzigmann, Sarah B Thomson

Pageof 1